US OptionsDetailed Quotes
TGTX250502C49000
- 0.55
- 0.000.00%
15min DelayClose Apr 28 16:00 ET
0.00High0.00Low
0.55Open0.55Pre Close0 Volume7 Open Interest49.00Strike Price0.00Turnover147.29%IV17.89%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type0.1732Delta0.0405Gamma76.42Leverage Ratio-0.2110Theta0.0007Rho13.24Eff Leverage0.0110Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet